Prostate News and Research

RSS

CWRU awarded two NIH grants to create pathology image informatics platform

Case Western Reserve University researchers have been awarded two grants totaling $3.16 million from the National Institutes of Health to create analytic software for managing, annotating, sharing and analyzing digital pathology imaging data.

12 Nov 2015

Sorafenib increases progression-free survival and disease control rate in NSCLC patients

Sorafenib, a tyrosine kinase inhibitor (TKI) targeting the receptors for vascular endothelial growth factor, platelet derived growth factor, and mast/stem cell growth factor, modestly increases progression-free survival (PFS), time to progression, and disease control rate in non-small cell lung cancer (NSCLC) patients who have relapsed or failed two or three previous treatment regimens.

10 Nov 2015

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.

9 Nov 2015

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.

6 Nov 2015

New protein supplement lowers cholesterol, prevents osteoporosis

Scientists developed a supplement to maintain optimal health that contributes to the growth and development of children and adolescents. It also prevents osteoporosis and certain cancers such as breast and prostate.

5 Nov 2015

Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.

5 Nov 2015

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges.

4 Nov 2015

$Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture$

Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the initiation of dosing in the company's Phase 2 clinical trial of VK5211 in patients who recently suffered a hip fracture.

3 Nov 2015

UCLA study finds cost variation across entire care process for low-risk prostate cancer

Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his post-treatment follow-up testing - using time-driven activity-based costing. And they found a wide variation in costs for the various available treatments that remained consistent over a 12-year period, indicating a better method to monitor costs could save valuable healthcare dollars, said study first author Dr. Aaron Laviana, a fifth year urology resident.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.

31 Oct 2015

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

Academics at Loughborough University hope to boost early detection rates of cancer in developing countries with their portable lab-in-a-briefcase that can operate even at high temperatures.

31 Oct 2015

University of Kansas professor recognized with MERIT Award

Emily Scott, professor of medicinal chemistry at the University of Kansas, has been recognized with a MERIT Award from the National Institutes of Health's National Institute of General Medical Sciences. It's a rare and important recognition -- researchers can receive them only once in a career.

30 Oct 2015

Transition Therapeutics Ireland signs agreement for investigator-led TT701 Phase 2 clinical study

Transition Therapeutics Inc. announced today that Transition Therapeutics Ireland Limited has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and Women's Hospital.

30 Oct 2015

Study uncovers new genetic variants linked to increased risk of testicular cancer

A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.

27 Oct 2015

Genetic discovery sheds light on how prostate cancer develops and spreads

A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.

27 Oct 2015

Revolutionary prostate biopsy approach more accurate at diagnosing prostate cancer

A revolutionary prostate biopsy approach uses fewer needles and is more accurate for diagnosing prostate cancer. It is done during a real time MRI (magnetic resonance imaging) scan that clearly shows suspicious sites. When done by an expert radiologist using a highly powerful magnet, only a minimum number of needles are used to sample suspicious abnormalities.

26 Oct 2015

Hispanic, Medicaid patients less likely to receive regional anesthesia during hip and knee replacement surgery

Patients who are black, Hispanic, on Medicaid or are uninsured may be less likely to receive regional anesthesia during hip and knee replacement surgery, possibly putting them at greater risk of serious complications, according to a study of more than 1 million orthopedic surgeries being presented at the ANESTHESIOLOGY 2015 annual meeting.

26 Oct 2015

New approaches to treating lung cancer patients in New Mexico

This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined.

26 Oct 2015

PCF announces 19 new Young Investigator Awards

The Prostate Cancer Foundation announced 19 new Young Investigator (YI) Awards at the 22nd Annual Scientific Retreat in Washington, DC, held October 8-10, 2015. Awardees were selected from a pool of 107 applicants from 65 institutions in 9 countries.

22 Oct 2015

Prostate News and Research

CWRU awarded two NIH grants to create pathology image informatics platform

Sorafenib increases progression-free survival and disease control rate in NSCLC patients

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

New protein supplement lowers cholesterol, prevents osteoporosis

Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture

UCLA study finds cost variation across entire care process for low-risk prostate cancer

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

University of Kansas professor recognized with MERIT Award

Transition Therapeutics Ireland signs agreement for investigator-led TT701 Phase 2 clinical study

Study uncovers new genetic variants linked to increased risk of testicular cancer

Genetic discovery sheds light on how prostate cancer develops and spreads

Revolutionary prostate biopsy approach more accurate at diagnosing prostate cancer

Hispanic, Medicaid patients less likely to receive regional anesthesia during hip and knee replacement surgery

New approaches to treating lung cancer patients in New Mexico

PCF announces 19 new Young Investigator Awards

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News